Browse through the free CME activity opportunities available below and click Begin to earn CME and/or MOC today!
You must be logged in to access any CME-accredited content.
Create a Free Account! Click here for help creating an account
Log in now or create a free account today!
Already a member? Click here to log in
Begin |
 | Learning Objectives:- Incorporate key measures and updated algorithms for risk when assessing patients for obesity and its comorbidities
- Recognize obesity as a disease and understand associated barriers to initiating and maintaining care
- Evaluate and apply intensive lifestyle interventions that take effectiveness, access to support, and patient preference into consideration
- Apply evidence-based guidelines in the selection and use of pharmacotherapy to treat patients with obesity that takes risk factors into consideration
- Devise patient-centered strategies to overcome challenges in long-term weight loss maintenance
|
| Topic Area: Obesity | Format: Webcast | Credits:
2.50 ABIM MOC
2.50 AMA PRA Category 1 Credits™ | Course Expires: 04/30/2019 |
Begin |
 | Learning Objectives:- Discuss the biology and genetic underpinnings of dyslipidemia as it relates to PCSK9 and the LDL receptor
- Assess the value of newer therapies to treat patients with familial hypercholesterolemia and apply treatment
- Evaluate strategies to optimize commonly used lipid-lowering therapies in patients with familial hypercholesterolemia
|
| Topic Area: Lipid Disorders and Fatty Liver Diseases | Format: Webcast | Credits:
2.0 ABIM MOC
2.0 AMA PRA Category 1 Credits™ | Course Expires: 04/30/2019 |
Begin |
 | Learning Objectives:- Describe existing clinical challenges in the diagnosis and management of osteoporosis and identify common barriers in management
- Apply current guidelines and state of care methods when assessing and treating patients at risk for low trauma fractures or living with osteoporosis
- Interpret the mechanism of action, benefits, and limitations of emerging osteoporosis therapies, and recognize the potential impact of current trials on practice
|
| Topic Area: Bone and Calciotropic Hormones | Format: Webcast | Credits:
2.50 ABIM MOC
2.50 AMA PRA Category 1 Credits™ | Course Expires: 04/30/2019 |
Begin |
 | Learning Objectives:- Personalize treatment selection for patients with RAI-refractory DTC based on available data and approved agents
- Implement strategies to mitigate toxicities associated with RAI-refractory DTC therapies
- Evaluate data from late-stage clinical trials of emerging therapies for RAI-refractory DTC
|
| Topic Area: Thyroid/HPT Axis | Format: Webcast | Credits:
1 AMA PRA Category 1 Credits™ | Course Expires: 03/15/2019 |
Facebook
Twitter
LinkedIn
Google+
Forward